Furthermore, loss of the NF2 suppressor gene at chromosome 22 has been demonstrated in a higher percentage (50–60%) of meningiomas, and supratentorial meningiomas with NF2 alterations had higher MIB-1 indices and a shorter time to tumor progression [62,63]. The gene discussed is NF2; the disease is neoplasm.